合肥野生动物园袋鼠口鼻腔带菌情况调查

[目的]对合肥野生动物园袋鼠口腔和鼻腔的带菌情况进行调查。[方法]从袋鼠口腔和鼻腔中分离致病菌,并采用细菌形态学和分子生物学方法对其进行鉴定。选用14种常用抗菌药物,采用纸片扩散法进行药敏试验。[结果]14份袋鼠口腔样本中均分离到革兰氏阳性球菌,其中12只袋鼠口腔分离到葡萄球菌,占85.7%;从4只袋鼠口腔分离到链球菌,占28.5%;从2只袋鼠口腔同时分离到葡萄球菌和链球菌,占14.3%。同时,从14只袋鼠鼻腔中均分离到葡萄球菌。药敏试验结果表明,ZS-1菌株对磺胺类、大环内酯类、喹诺酮类、头孢菌素类、磷霉素类、林可霉素类和四环素类药物敏感。鼻腔中细菌对磷霉素类、喹诺酮类和四环素类药物敏感。口腔中的细菌对14种常用抗菌药物均无耐药性,鼻腔中分离的细菌对卡那霉素、复方新诺明、强力霉素和阿莫西林耐药。[结论]研究结果可为袋鼠口腔和鼻腔细菌感染类疾病的有效防治提供科学依据。     

The effect of bentonite concentration on the drug delivery efficacy of a pH-sensitive alginate/bentonite hydrogel

We produced a protein loaded, pH-sensitive alginate-bentonite hydrogel for wound dressings. Alginate is a nontoxic polysaccharide with favorable pH-sensitive properties that make it useful for the intestinal delivery of protein drugs. However, the use of alginate for drug delivery is limited by drug leaching and rapid dissolution of alginate at the higher pH, which may result in lower entrapment efficiency and a burst in the release of entrapped protein drugs. To overcome these problems, we created a novel cross-linked alginate-bentonite hydrogel by combining mineral-rich bentonite with the alginate matrix along with an additive to ensure controlled release. We analyzed the gel in the drug loading process in an aqueous environment by looking at the release profiles of a model protein drug (BSA) from the hydrogel at pH values of 4.5, 5.2 (skin area) and 7.4, 9.2 (wound area). The swelling ratio decreased with bentonite concentration, but did not fall below 6. The rate of drug release was slowest at a pH value of 4.5 and fastest at a pH value of 9.2. The rate of drug release decreased with bentonite concentration. The presence of bentonite prevents the rapid dissolution of alginate at the higher pH, ensuring the controlled release of the entrapped drug.     

高效液相色谱法测定杨树花口服液中水杨苷的含量

建立了高效液相色谱分离测定杨树花口服液中水杨苷含量的方法。采用Waters XBridge C18色谱柱（150mm×4．6mm,5μm）,以甲醇-水（10：90）为流动相,流速为1．0mL／min,检测波长269nm,柱温30℃。水杨苷的线性范围为0．025～0．5mg／mL（r=0．9995）,平均加样回收率（n=6）为100．8％,RSD为1．49％。建立的方法准确、快速,操作简便,可用于杨树花口服液中水杨苷的含量测定。     

Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein

The major structural protein VP2 of porcine parvovirus (PPV) was used as the model parvovirus antigen, which has been expressed in Lactobacillus casei fusing with Escherichia coli heat-labile enterotoxin B subunit (LTB) as mucosal adjuvant. The VP2-LTB DNA fragment was cloned into vector pPG611 or pPG612 to generated inducible surface-displayed and secretion expression systems based on xylose promoter, designated as rLc:pPG611-VP2-LTB (recombinant L. casei) and rLc:pPG612-VP2-LTB, respectively. Expression of the fusion protein was verified by SDS-PAGE, Western blot immunofluorescence and electron microscopy. It was observed that the level of IgG or sIgA from mice orally immunized with VP2-LTB was higher than that from mice received VP2 and negative control, which demonstrated significantly statistically different. Especially, the titer of IgG or sIgA in mice immunized with rLc:pPG612-VP2-LTB is the highest in this study. In summary, LTB as mucosal adjuvant was able to effectively facilitate induction of mucosal and systemic immunity by L. casei-expressing VP2 fusion protein.     

口服补液盐的临床应用与动物实验研究

作者于1983年开始将以葡萄糖—钠泵学说为理论的口服补液盐(ORS)技术引入我国畜牧兽医领域,经过几年的临床研究;先后在防治犊牛、猪、雏鸡和犬的腹泻脱水等获得86～98.7％的成功率。健康绵羊ORS液吸收实验和与静脉输液、口服蒸溜水吸收比较实验证明,ORS液的各种成分在服后2小时内,不仅能被胃肠粘膜吸收,极显著改善红细胞压积(P<0.01),而且初步观察到促水分吸收的葡萄糖—钠泵现象。     

Passive immunisation of fish against vibriosis, comparison of intraperitoneal, oral and immersion routes

Passive immunisation of fish was conducted to determine whether anti-Vibrio anguillarum whole sera (AVA) and affinity-purified AVA raised in sheep, rabbits and rainbow trout (Oncorhynchus mykiss) were persistent when injected and orally administered into rainbow trout. These responses were compared with active immunisation by immersion in, and intraperitoneal (i.p.) injection with, formalin-killed V. anguillarum cells. Sheep and rabbit AVA were detected in rainbow trout sera for up to 70 days (half-life 21 days) after i.p. injection as determined by an enzyme-linked immunosorbent assay (ELISA). The relative percentage survival (RPS) of passively immunised rainbow trout challenged with virulent V. anguillarum after an injection was comparable to that of active immunisation by immersion after 1 month post-immunisation (p.i). Affinity-purified sheep and rabbit AVA exhibited the same protective potential as whole serum in rainbow trout. Rabbit and sheep immune sera diluted 1:8 and 1:50, respectively, provided equivalent protection as undiluted fish immune serum. An active immune response against passively acquired heterologous immunoglobulins was demonstrated by ELISA, with responses against sheep AVA being less than those against rabbit AVA. Rainbow trout given purified sheep AVA conjugated to LTB (the GM-1-binding subunit of Escherichia coli heat-labile toxin) and administered orally had an RPS of 37.5% at 15 days and 27% at 1 month p.i. In contrast, fish given sheep AVA conjugated to TraT (an internal membrane of E. coli) or in micellar form with Quil-A had RPSs of only 18.7 and 6.2%, respectively, after 15 days, and 13.3 and 0% after 1 month, respectively. The protection conferred by immune sera was shown to be due to the immunoglobulin component alone. Heat inactivation of the complement in sera had no effect on the potency of immune sera.     

Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: Clinical and laboratory evaluation

Recombinant-Feline Interferon-Omega (rFeIFN-ω) is an immune-modulator licensed for use subcutaneously in Feline Immunodeficiency virus (FIV) therapy. Despite oral protocols have been suggested, little is known about such use in FIV-infected cats. This study aimed to evaluate the clinical improvement, laboratory findings, concurrent viral excretion and acute phase proteins (APPs) in naturally FIV-infected cats under oral rFeIFN-ω therapy (0.1 MU/cat rFeIFN-ω PO, SID, 90 days). 11 FIV-positive cats were treated with oral rFeIFN-ω (PO Group). Results were compared to previous data from 7 FIV-positive cats treated with the subcutaneous licensed protocol (SC Group). Initial clinical scores were similar in both groups. Independently of the protocol, rFeIFN-ω induced a significant clinical improvement of treated cats. Concurrent viral excretion and APP’s variation were not significant in the PO Group. Oral rFeIFN-ω can be an effective alternative therapy for FIV-infected cats, being also an option for treatment follow-up in cats submitted to the licensed protocol.     

Study on the Relationship of Taiwan＇s aboriginal oral traditions and written literature

台湾原住民文学包括口传文学与书面文学两部分。口头传统与当代台湾原住民书面文学的关系不单单是源与流的关系,应该说当代台湾原住民书面文学是台湾原住民口头传统历史的叙述的文字发展＂,更是口头传统的历史延伸,两者紧紧地结合在一起,形成了当代台湾原住民文学独一无二的审美气质。     

蒙脱石散治疗肿瘤放化疗引起口腔黏膜炎71例临床分析

目的观察蒙脱石散治疗肿瘤放化疗引起口腔黏膜炎的效果．方法口腔黏膜炎患者71例,随机分为2组,1组为治疗组38例,用蒙脱石散治疗;另1组为对照组33例,用西瓜霜喷剂治疗．对其治疗效果进行比较．结果蒙脱石治疗组显效20例,有效10例,无效8例,总有效率78．9％;西瓜霜喷剂治疗组显效8例,有效10例,无效15例,总有效率54．5％．经统计学分析,蒙脱石组与西瓜霜喷剂组比较,X^2=4．802,P〈0．05,差异具有统计学意义．蒙脱石组疗效明显优于西瓜霜喷剂组,获得满意的效果．结论蒙脱石能迅速覆盖溃疡创面,明显减轻疼痛,促进溃疡愈合,见效快,疗效高,安全、无毒,值得临床推广应用．